This research report titled ‘Global Vascular Grafts Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This report also includes an up to date analysis and forecasts for various market segments and all geographical regions.
According to Barath Palada, a lead analyst at Technavio for cardiovascular devices research, “The global vascular grafts market is expected to witness steady growth during the forecast period. This is owing to the rising demand for endovascular aortic aneurysm treatment coupled with growing target population. In addition, the market is witnessing continuous technological innovation, regulatory approvals across all the regions, emergence of next-generation tissue engineered vascular grafts and drug-eluting vascular grafts.”
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
The market research analysis categorizes the global vascular grafts market into four major product segments. They are:
- Endovascular grafts
- Bypass grafts
- Hemodialysis grafts
- Peripheral grafts
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Global endovascular grafts market
This market segment accounted for the largest share of the global vascular grafts market in 2016. The global endovascular grafts market is expected to see the lucrative growth during the forecast period, owing to rising demand for technologically advanced endovascular graft. For instance, Medtronic’s Endurant II AAA Stent Graft System and Terumo's Anaconda AAA Stent Graft System are the major products in this segment. In addition, new product launches coupled with R&D activities will also have a positive impact on the market growth during the coming years. For instance, Altura Endovascular Stent Graft introduced by Lombard Medical is especially designed for treating patients with AAA. Furthermore, new regulatory product approval across various regions will contribute to the market growth during the forecast period.
Global bypass grafts market
The global bypass grafts market is likely to grow at a steady pace owing to the growing rate of bypass grafting and the increasing incidence of peripheral vascular disorder (PVD) and peripheral artery disease (PAD). In addition, new product launches will have a positive impact on the market in coming years. For instance, in late 2015, Vascular Flow Technologies launched Spiral Flow PV Bypass Graft, which is designed for treating PAD to reconstruct damaged blood vessels. Moreover, the affordable cost of this graft also drove its sales and will continue to do so during the forecast period as well.
“The global bypass grafts segment is growing due to the increasing prevalence of various cardiovascular diseases and diabetes, and the growing need for repeated vascularization procedure. In addition, the rising prevalence of PVD, PAD, and atherosclerosis, excessive smoking, high blood pressure, and high cholesterol level are the major factors driving the sales of the bypass grafts,” says Barath.
Global hemodialysis grafts market
The global hemodialysis grafts market is expected to witness lucrative growth during the forecast period owing to its growing usage in hemodialysis patient, who fail to respond to normal catheterization procedures. Hemodialysis grafts are the best substitute of hemodialysis catheters as the grafts cab be used reliably for a longer time, and the chance of infection from graft is four times lesser than the catheter. Further, the demand for hemodialysis grafts among the targeted population will increase as this graft can be used prolonged for 2-3 weeks post-surgery.
Global peripheral grafts market
The global peripheral grafts market is expected to witness lucrative growth owing to the high prevalence of PAD, growing geriatric population, rising popularity of MI procedures, technological advances, and new product launches. In early 2016, JOTEC launched E-ventus BX balloon expandable peripheral stent graft system. This peripheral graft system is specially designed for interventional therapy during dissections, ruptures, and aneurysms for iliac and renal arteries. Further, the new graft has shown the maximum flexibility, enabling it to facilitate extensive curvature of the native vessels. This peripheral graft has unique cobalt-chromium stent design to provide the high radial strength and has magnetic resonance imaging compatibility.
The top vendors highlighted by Technavio’s market research analysts in this report are:
- C.R. Bard
- B. Braun Melsungen
- Cook Medical
Browse Related Reports:
- Global Carotid Stents Market 2017-2021
- Global Cardiac Rhythm Management (CRM) Devices Market 2017-2021
- Global Cardiac Biomarkers Market 2017-2021
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.